Abstracts tagged "AA-amyloidosis and familial Mediterranean fever"

Abstract Number: 2749 • 2013 ACR/ARHP Annual Meeting
Amyloidosis and Its Related Factors In Patients With Familial Mediterranean Fever: A Nationwide Multicenter Study
Timucin Kasifoglu¹, Sule Yasar¹, Ismail Sari², Dilek Solmaz², Soner Senel³, Hakan Emmungil⁴, Levent Kilic⁵, Sibel Yilmaz Oner⁶, Fatih Yildiz⁷, Sedat Yilmaz⁸, Muhammet Cinar⁹, Duygu Ersozlu Bakirli¹⁰, Muge Aydin Tufan¹¹, Sema Yilmaz¹², Veli Yazisiz¹³, Yavuz Pehlivan¹⁴, Cemal Bes¹⁵, Gozde Yildirim Cetin¹⁶, Sukran Erten¹⁷, Emel Gonullu¹, Tuncer Temel¹⁸, Servet Akar², Kenan Aksu⁴, Umut Kalyoncu⁵, Haner Direskeneli¹⁹, Eren Erken¹¹, Bunyamin Kisacik²⁰, Mehmet Sayarlioglu²¹ and Cengiz Korkmaz²², ¹Rheumatology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey, ²Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ³Rheumatology, Kayseri Erciyes University School of Medicine, Kayseri, Turkey, ⁴Rheumatology, Ege University School of Medicine, Izmir, Turkey, ⁵Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey, ⁶Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ⁷Rheumatology, Cukurova University, School of Medicine, Adana, Turkey, ⁸Gulhane School of Medicine, Ankara, Turkey, ⁹Rheumatology, Gulhane School of Medicine, Ankara, Turkey, ¹⁰Rheumatology, Adana Numune Training and Research Hospital, Adana, Turkey, ¹¹Rheumatology, Cukurova University School of Medicine, Adana, Turkey, ¹²Department of Rheumatology, Selcuk University School of Medicine, Konya, Turkey, ¹³Rheumatology, Akdeniz University School of Medicine, Antalya, Turkey, ¹⁴Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, ¹⁵Rheumatology, Bolu Izzet Baysal School of Medicine, Bolu, Turkey, ¹⁶Rheumatology, Kahramanmaras University School of Medicine, Kahramanmaras, Turkey, ¹⁷Rheumatology, Ataturk Training and Research Hospital, Ankara, Turkey, ¹⁸Gastroenterology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey, ¹⁹Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ²⁰Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ²¹Rheumatology, Ondokuz Mayis University School of Medicine, Samsun, Turkey, ²²Eskisehir Osmangazi University, Eskisehir, Turkey
Background/Purpose: Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease that occurs worldwide and predominantly affects the populations arising from the Mediterranean origin. Secondary…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].